| CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties S Kuçi, Z Kuçi, H Kreyenberg, E Deak, K Pütsch, S Huenecke, C Amara, ... haematologica 95 (4), 651, 2010 | 221 | 2010 |
| Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation E Rettinger, AM Willasch, H Kreyenberg, A Borkhardt, W Holter, ... Blood, The Journal of the American Society of Hematology 118 (20), 5681-5688, 2011 | 138 | 2011 |
| The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells E Rettinger, S KuçI, I Naumann, P Becker, H Kreyenberg, M Anzaghe, ... Cytotherapy 14 (1), 91-103, 2012 | 135 | 2012 |
| Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation S Kuçi, E Rettinger, B Voß, G Weber, M Stais, H Kreyenberg, A Willasch, ... Haematologica 95 (9), 1579, 2010 | 100 | 2010 |
| Chimeric antigen receptor‐engineered cytokine‐induced killer cells overcome treatment resistance of pre‐B‐cell acute lymphoblastic leukemia and enhance survival S Oelsner, J Wagner, ME Friede, V Pfirrmann, S Genßler, E Rettinger, ... International journal of cancer 139 (8), 1799-1809, 2016 | 56 | 2016 |
| The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential … A Heinze, B Grebe, M Bremm, S Huenecke, TA Munir, L Graafen, ... Frontiers in immunology 10, 2816, 2019 | 54 | 2019 |
| Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis A Willasch, S Eing, G Weber, S Kuci, G Schneider, J Soerensen, A Jarisch, ... Bone marrow transplantation 45 (1), 181-189, 2010 | 51 | 2010 |
| Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models E Rettinger, V Meyer, H Kreyenberg, A Volk, S Kuçi, A Willasch, ... Frontiers in oncology 2, 32, 2012 | 48 | 2012 |
| Monitoring of hematopoietic chimerism after transplantation for pediatric myelodysplastic syndrome: real-time or conventional short tandem repeat PCR in peripheral blood or … AM Willasch, H Kreyenberg, N Shayegi, E Rettinger, V Meyer, M Zabel, ... Biology of blood and marrow transplantation 20 (12), 1918-1925, 2014 | 47 | 2014 |
| Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children M Merker, V Pfirrmann, S Oelsner, S Fulda, T Klingebiel, WS Wels, ... Oncotarget 8 (39), 66137, 2017 | 44 | 2017 |
| Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first … E Rettinger, S Huenecke, H Bonig, M Merker, A Jarisch, J Soerensen, ... Haematologica 101 (4), e153, 2016 | 40 | 2016 |
| Clearance of hematologic malignancies by allogeneic cytokine-induced killer cell or donor lymphocyte infusions M Merker, E Salzmann-Manrique, V Katzki, S Huenecke, M Bremm, ... Biology of Blood and Marrow Transplantation 25 (7), 1281-1292, 2019 | 36 | 2019 |
| Monitoring of circulating CAR T cells: validation of a flow cytometric assay, cellular kinetics, and phenotype analysis following tisagenlecleucel A Peinelt, M Bremm, H Kreyenberg, C Cappel, J Banisharif-Dehkordi, ... Frontiers in immunology 13, 830773, 2022 | 35 | 2022 |
| Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation E Rettinger, H Bonig, S Wehner, G Lucchini, A Willasch, A Jarisch, ... Bone marrow transplantation 48 (8), 1141-1143, 2013 | 35 | 2013 |
| Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience AM Willasch, E Salzmann-Manrique, T Krenn, M Duerken, J Faber, ... Bone Marrow Transplantation 52 (2), 201-208, 2017 | 34 | 2017 |
| Arming immune cells for battle: A brief journey through the advancements of T and NK cell immunotherapy P Wendel, LM Reindl, T Bexte, L Künnemeyer, V Särchen, N Albinger, ... Cancers 13 (6), 1481, 2021 | 33 | 2021 |
| Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation E Rettinger, M Merker, E Salzmann-Manrique, H Kreyenberg, T Krenn, ... Biology of blood and marrow transplantation 23 (1), 87-95, 2017 | 33 | 2017 |
| Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single‐center cohort study G Lucchini, AM Willasch, J Daniel, J Soerensen, A Jarisch, S Bakhtiar, ... Pediatric transplantation 20 (8), 1132-1136, 2016 | 31 | 2016 |
| CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany P Bader, C Rossig, M Hutter, FA Ayuk, CD Baldus, VL Bücklein, H Bonig, ... Blood Advances 7 (11), 2436-2448, 2023 | 28 | 2023 |
| ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma M Merker, J Wagner, H Kreyenberg, C Heim, LM Moser, WS Wels, ... Frontiers in immunology 11, 581468, 2020 | 28 | 2020 |
